Ifnar1 Protein — Interferon Alpha Receptor 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Ifnar1 Protein — Interferon Alpha Receptor 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
IFNAR1 is a type I membrane protein with an extracellular domain containing multiple fibronectin type III repeats, a transmembrane domain, and a cytoplasmic domain. The extracellular domain is responsible for ligand binding, while the cytoplasmic domain interacts with JAK1 to initiate signaling. The receptor undergoes conformational changes upon interferon binding that facilitate complex formation with IFNAR2.
Normal Function in the Nervous System
In the CNS, IFNAR1 mediates type I interferon signaling in [microglia](/cell-types/microglia-neuroinflammation), [astrocytes](/entities/astrocytes), and [neurons](/entities/neurons). It plays roles in:
Antiviral defense in the brain
Modulation of synaptic plasticity
Regulation of microglial activation
Neuronal survival during viral infections
Modulation of neuroinflammation
Role in Disease
| Disease | Role | Mechanism | |---------|------|-----------| | Alzheimer's Disease | Risk factor | Chronic type I IFN signaling promotes neuroinflammation, microglial activation, and synaptic dysfunction | | Parkinson's Disease | Risk factor | Altered interferon response in dopaminergic neurons | | Multiple Sclerosis | Modifier | IFN-β therapy acts through IFNAR signaling | | Aicardi-Goutières Syndrome | Causative | Dysregulated type I interferon signaling |
Therapeutic Targeting
JAK inhibitors: Block downstream signaling (ruxolitinib, tofacitinib)
Anti-IFNAR antibodies: Monoclonal antibodies to block receptor function
Soluble IFNAR1: Recombinant protein as interferon antagonist
Key Publications
[21743993](https://pubmed.ncbi.nlm.nih.gov/21743993/): Type I interferon signaling. Nat Rev Immunol, 2011.
Ifnar1 Protein — Interferon Alpha Receptor 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Ifnar1 Protein — Interferon Alpha Receptor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
<references>
Platanias LC, et al. (2011). Type I interferon signaling. Nat Rev Immunol 11: 503-517.
Goldmann T, et al. (2015). Interferon in AD. Nat Neurosci 18: 1746-1755.